Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type II diabetes mellitus in the Prevention of Renal and Vascular End-Stage Disease study

MLA

Robin P. F. Dullaart, et al. “Lipoprotein Insulin Resistance Index, a High-Throughput Measure of Insulin Resistance, Is Associated with Incident Type II Diabetes Mellitus in the Prevention of Renal and Vascular End-Stage Disease Study.” Journal of Clinical Lipidology, vol. 13, no. 1, Jan. 2019, pp. 129–37. EBSCOhost, https://doi.org/10.1016/j.jacl.2018.11.009.

APA

Robin P. F. Dullaart, Margery A. Connelly, Eke G. Gruppen, Irina Shalaurova, Stephan J. L. Bakker, Jose L. Flores-Guerrero, & Lyanne M. Kieneker. (2019). Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type II diabetes mellitus in the Prevention of Renal and Vascular End-Stage Disease study. Journal of Clinical Lipidology, 13(1), 129–137. https://doi.org/10.1016/j.jacl.2018.11.009

Chicago

Robin P. F. Dullaart, Margery A. Connelly, Eke G. Gruppen, Irina Shalaurova, Stephan J. L. Bakker, Jose L. Flores-Guerrero, and Lyanne M. Kieneker. 2019. “Lipoprotein Insulin Resistance Index, a High-Throughput Measure of Insulin Resistance, Is Associated with Incident Type II Diabetes Mellitus in the Prevention of Renal and Vascular End-Stage Disease Study.” Journal of Clinical Lipidology 13 (1): 129–37. doi:10.1016/j.jacl.2018.11.009.